+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Antineoplastic Agents Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antineoplastic Agents Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 193 Pages
  • Global
From
Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
Immunotherapy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Urothelial Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Urothelial Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Immuno-Oncology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
From
From
Oncolytic Virus Therapy Market Report 2026 - Product Thumbnail Image

Oncolytic Virus Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Checkpoint Inhibitors Market Report 2026 - Product Thumbnail Image

Checkpoint Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2026 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Throat Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Throat Cancer Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 267 Pages
  • Global
From
Oncolytic Virotherapy Market - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virotherapy Market - Global Strategic Business Report

  • Report
  • August 2026
  • 243 Pages
  • Global
From
Gastric Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer Market - Global Strategic Business Report

  • Report
  • August 2026
  • 582 Pages
  • Global
From
Oral Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Oral Cancer Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 182 Pages
  • Global
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 180 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • August 2026
  • 282 Pages
  • Global
From
Nasopharynx Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Nasopharynx Cancer Market - Global Strategic Business Report

  • Report
  • August 2026
  • 287 Pages
  • Global
From
From
From
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more